Search research articles
Contact Us
Filters
Showing results (81-90 of 159) with videos related to
Page
of 16
Sort By:
Acta Gastro-Enterologica Belgica
|
February 25, 2005
Oral fluoropyrimidines in colorectal cancer: a door open to the future?
Th Delaunoit, F Neczyporenko, A Hendlisz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Phase Ii trial of fotemustine in advanced colorectal cancer
H Bleiberg, D Becquart, J Michel, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial
H Bleiberg, B Gerard, O Dalesio, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
September 8, 1983
[Phase I study of alizapride in cancer patients treated with cisplatin]
C Nicaise, M Rozencweig, M Ortmans, et al.
Critical Reviews in Oncology/Hematology
|
August 11, 2000
Oxaliplatin clinical activity: a review
J L Misset, H Bleiberg, W Sutherland, et al.
Surgery, Gynecology & Obstetrics
|
December 1, 1977
Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinoma
H Bleiberg, M Rozencweig, E Longeval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Adequate number of patients are needed to evaluate adjuvant treatment in gastric cancer
H Bleiberg, T Sahmoud, A Di Leo, et al.
Pediatric Emergency Care
|
April 7, 2007
Low-dose ketamine: efficacy in pediatric sedation
Alan H Bleiberg, Christy A Salvaggio, Lonnie C Roy, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer
H O Klein, J Wils, H Bleiberg, et al.
Anti-Cancer Drugs
|
October 11, 2003
Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?
G Atalay, F Cardoso, M Paesmans, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 159) with videos related to
Sort By:
Page
of 16
Acta Gastro-Enterologica Belgica
|
February 25, 2005
Oral fluoropyrimidines in colorectal cancer: a door open to the future?
Th Delaunoit, F Neczyporenko, A Hendlisz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Phase Ii trial of fotemustine in advanced colorectal cancer
H Bleiberg, D Becquart, J Michel, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial
H Bleiberg, B Gerard, O Dalesio, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
September 8, 1983
[Phase I study of alizapride in cancer patients treated with cisplatin]
C Nicaise, M Rozencweig, M Ortmans, et al.
Critical Reviews in Oncology/Hematology
|
August 11, 2000
Oxaliplatin clinical activity: a review
J L Misset, H Bleiberg, W Sutherland, et al.
Surgery, Gynecology & Obstetrics
|
December 1, 1977
Peritoneoscopy as a diagnostic supplement to liver function tests and liver scan in patients with carcinoma
H Bleiberg, M Rozencweig, E Longeval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Adequate number of patients are needed to evaluate adjuvant treatment in gastric cancer
H Bleiberg, T Sahmoud, A Di Leo, et al.
Pediatric Emergency Care
|
April 7, 2007
Low-dose ketamine: efficacy in pediatric sedation
Alan H Bleiberg, Christy A Salvaggio, Lonnie C Roy, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer
H O Klein, J Wils, H Bleiberg, et al.
Anti-Cancer Drugs
|
October 11, 2003
Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?
G Atalay, F Cardoso, M Paesmans, et al.
Page
of 16